HOME >> BIOLOGY >> NEWS
Drug tested for HIV prevention in Baltimore

As effective vaccines against HIV remain elusive, Johns Hopkins researchers have completed the first tests to see if a drug already used to treat HIV infection might one day be used to prevent sexual and blood-borne transmission of the virus that causes AIDS.

Reported in the March 7 issue of the journal AIDS (available online now), the 12-week study of nevirapine in Baltimore is believed to be the first in the United States to evaluate a pre-exposure, drug-based prevention strategy for adults at high risk, say the researchers. Previous strategies have focused on behavioral changes such as condom use and clean needles.

"This is a new concept for prevention of HIV infection," says J. Brooks Jackson, M.D., M.B.A., director of pathology and leader of the study. "A combination of drugs is used to treat HIV infection, but we want to see if long-term, low doses of one of these drugs can prevent new HIV infections in people at high risk. HIV infection rates are fairly steady in the United States, but skyrocketing elsewhere. We can't afford to wait for a vaccine."

When taken twice a day, nevirapine is one part of routine anti-retroviral therapy to keep HIV infection from resulting in AIDS. In small, one-time-only doses, the Johns Hopkins researchers already have proven -- overseas -- that nevirapine cuts in half the risk an HIV-infected mother will pass the virus to her baby during childbirth.

The new study tested the safety of three different doses of nevirapine all just a fraction of the treatment dose in 33 people at high risk of contracting HIV because of sexual practices or injection drug use. No serious adverse side effects related to nevirapine were seen in any participants, and none contracted HIV during the study period, the scientists report.

"This study wasn't designed to test whether nevirapine could in fact prevent HIV transmission, but it would have been bad for the future of this effort if we'd detected
'"/>

Contact: Joanna Downer
jdowner1@jhmi.edu
410-614-5105
Johns Hopkins Medical Institutions
24-Feb-2003


Page: 1 2 3

Related biology news :

1. Gene therapy tested to protect bone marrow during chemotherapy
2. Dr. Robot tested at Hopkins
3. Scientist: motion sickness drug scopolamine should be tested as new nerve agent treatment
4. Next-generation AIDS vaccine for healthy individuals being tested for safety, tolerability at UC Davis
5. Leader in cancer treatment and prevention research honored
6. OHSU researchers discover possible method for early detection, prevention of premature birth
7. Colleagues to recognize research leadership in cancer detection, prevention and treatment
8. Rutgers cancer prevention expert calls for FDA action to reduce colon cancer and osteoporosis
9. Indoor mold, building dampness linked to respiratory problems and require better prevention
10. Insight into transplant rejection might lead to novel prevention therapies
11. Scientists making advances in cancer prevention, detection and treatment to receive awards

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/2/2019)... ... May 01, 2019 , ... ... families insight into their future children, announces a new publication titled, “ Self-Collection ... journal of Pregnancy and Child Health. Previous studies had only shown early gender ...
(Date:4/27/2019)... ... April 26, 2019 , ... Washington State University’s Center for ... than 30 student venture teams, representing nearly 150 students, presented their business ideas ... The top five teams in the College League were awarded prize money with ...
(Date:4/25/2019)... ... 23, 2019 , ... In recent years the neurocognitive effects ... in many cases the magnitude of these deficits and the long-term impact on ... neurocognitive effects may impact developmental trajectories, and patients are often so unwell at ...
Breaking Biology News(10 mins):
(Date:4/15/2019)... ... April 15, 2019 , ... ... construction of a $2 million bench plant expansion to increase production of methylene ... in the design and construction of Sirrus’ full-scale production facility, which is scheduled ...
(Date:4/10/2019)... ... April 10, 2019 , ... ... manufacturing technology leaders, have locked into multiple agreements to help companies advance ... the regenerative medicine industry, ranging from synthetic biology companies that are gene ...
(Date:4/9/2019)... Calif. (PRWEB) , ... April 09, 2019 , ... ... services firm focused on increasing the capacity of life sciences organizations to accelerate ... Cloud Assurance platform in the past 12 months. , USDM’s ...
(Date:4/9/2019)... ... April 09, 2019 , ... The American Society ... of the Society's leadership team, including a new addition to the presidential line of ... their peers to join the Society's leadership team for a three-year term (2019-2021). , ...
Breaking Biology Technology:
Cached News: